跳至主要内容
临床试验/NCT05534776
NCT05534776招募中不适用

Validation of 5-Point Investigator Global Assessments for Pemphigus

Premier Specialists, Australia7 个研究点 分布在 7 个国家目标入组 40 人开始时间: 2022年9月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
7
主要终点
Pemphigus Disease Activity Index (PDAI) Score

研究概览

简要总结

This study aims to explore the reliability and validity of newly developed Investigator Global Assessments (IGAs) in scoring the severity of pemphigus. IGAs are simple 5-point scales ranging from clear - severe and are preferred by the FDA as endpoints in clinical trials.

详细描述

This study aims to obtain statistical data regarding the inter-rater and intra-rater reliability of the IGAs, Pemphigus Disease Activity Index (PDAI) and Autoimmune Bullous Skin Disease Intensity Score (ABSIS) as well as the convergent validity of the IGAs with the PDAI and objective component of the ABSIS.

Photograph sets of pemphigus lesions will be gathered from the lead site and participant sites. They will be de-identified and printed in a two hardcopy booklets; the first containing 20 photo sets and the second containing 17 new photo sets and 3 repeat photo sets. In the first part of the study, 8 dermatologists will score 20 sets of photographs of pemphigus lesions (a mixture of skin and mucosal lesions), using the IGAs for pemphigus as well as the PDAI and ABSIS. The first booklet will be mailed to dermatologists and they will use the booklet to score each photo set and will submit their scores in a confidential online survey. In the second part of the study, the second booklet will be sent to dermatologists in the same manner 4 weeks later, and each dermatologist will score the photo sets using the same scoring tools. It is estimated that each scoring session will take two hours to complete. Data gathered here will allow for calculation of inter-rater reliability and intra-rater reliability of the IGAs and convergent validity of the IGAs with PDAI and ABSIS.

Later, a sub-study will occur to calculate minimal clinically important differences (MCID) for the IGAs and PDAI. This will involve scoring pemphigus severity of patients at Premier Specialists using PDAI and IGA scores and a Likert score to classify patients as improved, stable or deteriorated compared to previous visits.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having pemphigus diagnosed by a qualified dermatologist
  • Aged 18 or older at the time of photography

排除标准

  • Those whose photographs are unable to be adequately de-identified

结局指标

主要结局

Pemphigus Disease Activity Index (PDAI) Score

时间窗: Baseline

Possible score from 0-263

Autoimmune Bullous Skin Disorder Intensity Score (ABSIS)

时间窗: Baseline

Possible score from 0-206

IGA-PV-M (D/P/F), IGA-PV-S (D/P/F), IGA-PF (D/P/F)

时间窗: Baseline

IGA score of pemphigus severity, possible score from 0-4

次要结局

未报告次要终点

研究者

发起方
Premier Specialists, Australia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dedee Murrell

Professor, Director of Premier Specialists

Premier Specialists, Australia

研究点 (7)

Loading locations...

相似试验